Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This book covers intentional design aspects for combinations of drugs, single-molecule hybrids with potential or actual multiple actions, pro-drugs which could yield multiple activity outcomes, and future possibilities. The approach of the book is interdisciplinary, and it provides greater understanding of the complex interplay of factors involved in the medicinal chemistry design and laboratory development of multiply active antibacterials. The scope of the book appeals to readers who are researching in the field of antibacterials using the approach of medicinal chemistry design and drug development. …mehr
This book covers intentional design aspects for combinations of drugs, single-molecule hybrids with potential or actual multiple actions, pro-drugs which could yield multiple activity outcomes, and future possibilities. The approach of the book is interdisciplinary, and it provides greater understanding of the complex interplay of factors involved in the medicinal chemistry design and laboratory development of multiply active antibacterials. The scope of the book appeals to readers who are researching in the field of antibacterials using the approach of medicinal chemistry design and drug development.
John Bremner was born in Perth, Western Australia and after completion of his undergraduate studies at the University of Western Australia he undertook a PhD at the Australian National University. After a further year at Harvard University as a Research Fellow he returned to Australia to take up a Lectureship in Chemistry at the University of Tasmania. Later, on sabbatical leave, he completed a Diploma in Chemical Pharmacology at the University of Edinburgh. In 1991 he was appointed as Professor of Organic Chemistry at the University of Wollongong in NSW, Australia. He retired in 2007 and is now an Emeritus Professor of the University of Wollongong. He is a Fellow of The Royal Australian Chemical Institute and received a Distinguished Fellow Award of the RACI in 2011. In 2001 he received the Adrien Albert Award in medicinal chemistry. He is also a Fellow of the Royal Society of Chemistry.
Inhaltsangabe
Introduction to Antibacterials.- Antibacterial Combinations.- Single Molecule Non-cleavable Multiply Active Antibacterials.- Design Principles and Development of Multiply Active Pro-drug Antibacterials.- Future Possibilities.
Introduction to Antibacterials.- Antibacterial Combinations.- Single Molecule Non-cleavable Multiply Active Antibacterials.- Design Principles and Development of Multiply Active Pro-drug Antibacterials.- Future Possibilities.
Introduction to Antibacterials.- Antibacterial Combinations.- Single Molecule Non-cleavable Multiply Active Antibacterials.- Design Principles and Development of Multiply Active Pro-drug Antibacterials.- Future Possibilities.
Introduction to Antibacterials.- Antibacterial Combinations.- Single Molecule Non-cleavable Multiply Active Antibacterials.- Design Principles and Development of Multiply Active Pro-drug Antibacterials.- Future Possibilities.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497